Literature DB >> 4157358

Comparison of in vitro antibacterial activities of gentamicin and verdamicin.

P K Yu, J A Washington.   

Abstract

The in vitro activities of verdamicin and gentamicin were studied in parallel against 1,049 bacterial isolates. Verdamicin demonstrated activity similar to that of gentamicin against members of the family Enterobacteriaceae and against Pseudomonas aeruginosa at 2 and 8 mug/ml, respectively. Proteus rettgeri and Providencia stuartii were notably more susceptible to verdamicin. The new aminoglycoside was also highly active against staphylococci but was not effective against group D streptococci.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4157358      PMCID： PMC444685          DOI： 10.1128/AAC.6.4.526

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics.

Authors:  R Benveniste; J Davies
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.

Authors:  K E Price; D R Chisholm; M Misiek; F Leitner; Y H Tsai
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

3.  In vitro studies of BB-K8, a new aminoglycoside antibiotic.

Authors:  G P Bodey; D Stewart
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

4.  Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii.

Authors:  J A Washington; D H Senjem; A Haldorson; A H Schutt; W J Martin
Journal:  Am J Clin Pathol       Date:  1973-12       Impact factor: 2.493

5.  Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors:  W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

6.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

7.  Resistance of Pseudomonas aeruginosa to gentamicin.

Authors:  P Chadwick
Journal:  Can Med Assoc J       Date:  1973-10-06       Impact factor: 8.262
  7 in total
  1 in total

1.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.